2021 annual financial data

Keros Therapeutics 2021 Financial results

Direct answer

Revenue was 20,100,000 USD.

Operating income was -56,373,000 USD and net income was -58,744,000 USD.
Operating cash flow was -62,148,000 USD.

Get free Keros Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
20,100,000 USD
Operating income
-56,373,000 USD
Net income
-58,744,000 USD
Operating cash flow
-62,148,000 USD